Details for 2016802132

Up to date per 01.04.2026

Actions

Title / Product Name

KOMBINATION VON CANRENOATE UND EXENATIDE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016802132

EP Publication Number

3370756

E-Number

1253421

Language

PCT Number

IB16001582

Publication Date

12.09.2018 A

08.04.2020 B1

Registration Date

08.04.2020

AT Publication Date

15.04.2020

Application Date

04.11.2016

Registration Number

Priorities

06.11.2015

20150100486

IPC

A61K 38/13 20060101AFI20170523BHEP

Maximum Duration of Protection

04.11.2036

Owner

Genesis Pharma SA270 Kifissias Avenue 15232 AthensGR

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

VOGIATZIS, GeorgeGenesis Pharma SA 270 Kifissias Avenue 15232 AthensGR

Information about Fees